Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fibrinogen Hillsborough: a novel gammaGly309Asp dysfibrinogen with impaired clotting.

Blood - 15 May 2002

Mullin Jennifer L, Brennan Stephen O, Ganly Peter S, George Peter M

Abstract excerpt

We present a novel gamma-chain dysfibrinogen that was discovered in a 32-year-old asymptomatic man admitted to the hospital after a car accident. He presented with a low fibrinogen concentration, 0.5 mg/mL, and a prolonged thrombin clotting time, 58 seconds. Analysis of purified fibrinogen by sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed a gamma-chain variant with an apparently higher...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aspartic Acid
Share to Biopolymers
Share to Blood Coagulation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Fibrinogens, Abnormal

Share to Glycine

Share to Molecular Weight

Share to Protein Subunits

Share to Thrombin

Source

Identifiers

PMID: 11986213
DOI: 10.1182/blood.v99.10.3597

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fibrinogen Hillsborough: a novel gammaGly309Asp dysfibrinogen with impaired clotting.PMID 11986213Read ↗

Fibrinogen Mannheim II: a novel gamma307 His-->Tyr substitution in the gammaD domain causes hypofibrinogenemia.Semantic proximity Read ↗

Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function.Semantic proximity Read ↗

gamma-Chain dysfibrinogenemias: molecular structure-function relationships of naturally occurring mutations in the gamma chain of human fibrinogen.Semantic proximity Read ↗

A novel γ-chain mutation p.Asp318His in a Chinese family with dysfibrinogenemia.Semantic proximity Read ↗

Fibrinogen Baltimore I: polymerization defect associated with a gamma 292Gly----Val (GGC----GTC) mutation.Semantic proximity Read ↗

A novel missense mutation (FGG c.1168G > T) in the gamma chain of fibrinogen causing congenital hypodysfibrinogenemia with bleeding phenotype.Semantic proximity Read ↗

Defective fibrinogen polymerization associated with a novel gamma279Ala-->Asp mutation.Semantic proximity Read ↗

Hypofibrinogenaemia associated with a novel heterozygous gamma289 Ala -->Val substitution (fibrinogen Dorfen).Semantic proximity Read ↗

Two symptomatic cases of dysfibrinogenemia in China: one with gamma-chain Arg275Cys mutation and another without detectable mutation in fibrinogen genes.Semantic proximity Read ↗

A new substitution, gamma 358 Ser-->Cys, in fibrinogen Milano VII causes defective fibrin polymerization.Semantic proximity Read ↗

Diagnosis, clinical features and molecular assessment of the dysfibrinogenaemias.Semantic proximity Read ↗

The molecular basis of quantitative fibrinogen disorders.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.